Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Scinai Immunotherapeutics Ltd. - American Depositary Shares (NQ:SCNI)

0.7377 +0.0208 (+2.90%)
Streaming Delayed Price Updated: 11:22 AM EST, Dec 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Scinai Immunotherapeutics Ltd. - American Depositary Shares

< Previous 1 2 3 4 5 6 Next >
Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Secures $1.33 Million from Registered Direct Offering to Boost Commercial Development
Via Investor Brand Network
News headline image
Scinai Immunotherapeutics to Showcase its end-to-end cGMP Biologics CDMO Services at CPHI Barcelona 2023
Targeting biotech companies with drug production process development and optimization, analytical methods development, and GMP production for clinical trials 
From Scinai Immunotherapeutics Ltd.
Via GlobeNewswire
Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Finalizes Rebrand to Reflect New Strategic Direction, Diversification
Via Investor Brand Network
CDC Avails $262M to New Network Aimed at Responding to Future Disease Outbreaks
Via Investor Brand Network
Why Food Allergy Prevalence Is Growing
Via Investor Brand Network
Inverse Vaccines Show Promise Against Autoimmunity
Via Investor Brand Network
BioMedNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Closes on $1.33M Registered Direct Offering
Via Investor Brand Network
News headline image
Scinai Immunotherapeutics Announces Closing of $1.33 Million Registered Direct Offering
From Scinai Immunotherapeutics Ltd.
Via GlobeNewswire
Study Shows Climate Change Impacts Infectious Disease Risks
Via Investor Brand Network
Topics Climate Change
News headline image
Why Novonix Shares Are Trading Higher By 27%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗
Gainers MSP Recovery, Inc. (NASDAQ: LIFW) shares jumped 127.8% to $0.1269. The company recently reported second-quarter results. 
Via Benzinga
BioMedNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Announces $1.33M Registered Direct
Via Investor Brand Network
News headline image
Stocks That Hit 52-Week Lows On Friday ↗
  Friday's session saw 169 companies set new 52-week lows. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Scinai Immunotherapeutics Announces $1.33 Million Registered Direct Offering
From Scinai Immunotherapeutics Ltd.
Via GlobeNewswire
BioMedNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Reports on Plaque Psoriasis Treatment Study
Via Investor Brand Network
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
 
Via Benzinga
News headline image
Scinai Immunotherapeutics Innovative Plaque Psoriasis Treatment Shows Encouraging Preclinical Results
From Scinai Immunotherapeutics Ltd.
Via GlobeNewswire
Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) NanoAbs for Psoriasis Treatment May Offer Significant Advantages Over Apogee
Via Investor Brand Network
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.